Not surprisingly, CA exhibited a considerable ability to mitigate obesity (Figure 3K; Figure S3J–M, Supporting Information), activate FXR, and modulate the expression of inflammation‐related genes (Figure 3L). The gene discussed is NR1H4; the disease is obesity due to melanocortin 4 receptor deficiency.